{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:47:19Z","timestamp":1776235639739,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019476","name":"Siriraj Foundation","doi-asserted-by":"crossref","award":["ID-003658"],"award-info":[{"award-number":["ID-003658"]}],"id":[{"id":"10.13039\/100019476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019476","name":"Siriraj Foundation","doi-asserted-by":"crossref","award":["ID-003658"],"award-info":[{"award-number":["ID-003658"]}],"id":[{"id":"10.13039\/100019476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019476","name":"Siriraj Foundation","doi-asserted-by":"crossref","award":["ID-003658"],"award-info":[{"award-number":["ID-003658"]}],"id":[{"id":"10.13039\/100019476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019476","name":"Siriraj Foundation","doi-asserted-by":"crossref","award":["ID-003658"],"award-info":[{"award-number":["ID-003658"]}],"id":[{"id":"10.13039\/100019476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019476","name":"Siriraj Foundation","doi-asserted-by":"crossref","award":["ID-003658"],"award-info":[{"award-number":["ID-003658"]}],"id":[{"id":"10.13039\/100019476","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NSTDA Research Chair Grant, National Science and Technology Development Agency"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Allergic contact dermatitis (ACD) is a type IV hypersensitivity mainly mediated by\u00a0Th1\/Th17 immune response. Topical corticosteroid is currently the first-line treatment for allergic contact dermatitis (ACD) and systemic administration of immunosuppressive drugs are used in patients with severe disseminated cases. However, increased risk of adverse effects has limited their use. Thus, the development of a novel immunosuppressant for ACD with low toxicity is a challenging issue. In this study, we began our study by using a murine contact hypersensitivity (CHS) model of ACD to examine the immunosuppressive effects of DYRK1B inhibition. We found that mice treated with a selective DYRK1B inhibitor show reduced ear inflammation. In addition, a significant reduction of Th1 and Th17 cells in the regional lymph node upon DYRK1B inhibition was observed by FACS analysis. Studies in vitro further revealed that DYRK1B inhibitor does not only suppressed Th1 and Th17 differentiation, but also promotes regulatory T cells (Treg) differentiation. Mechanistically, FOXO1 signaling was enhanced due to the suppression of FOXO1\n                    <jats:sup>Ser329<\/jats:sup>\n                    phosphorylation in the presence of DYRK1B inhibitor. Therefore, these findings suggest that DYRK1B regulates CD4 T cell differentiation through FOXO1 phosphorylation and DYRK1B inhibitor has a potential as a novel agent for treatment of ACD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-34211-x","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T13:01:56Z","timestamp":1682773316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1\/Th17 immune response"],"prefix":"10.1038","volume":"13","author":[{"given":"Thamrong","family":"Wongchang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panwadee","family":"Pluangnooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adisak","family":"Wongkajornsilp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Thumkeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitipong","family":"Soontrapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"34211_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-021-00277-y","volume":"7","author":"PL Scheinman","year":"2021","unstructured":"Scheinman, P. L. et al. Contact dermatitis. Nat. Rev. Dis. Primers. 7, 38. https:\/\/doi.org\/10.1038\/s41572-021-00277-y (2021).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"34211_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.anai.2020.10.003","volume":"126","author":"KK Brar","year":"2021","unstructured":"Brar, K. K. A review of contact dermatitis. Ann. Allergy Asthma Immunol. 126, 32\u201339. https:\/\/doi.org\/10.1016\/j.anai.2020.10.003 (2021).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"34211_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4049\/jimmunol.178.1.605","volume":"178","author":"K Ishizaki","year":"2007","unstructured":"Ishizaki, K. et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J. Immunol. 178, 605\u2013612. https:\/\/doi.org\/10.4049\/jimmunol.178.1.605 (2007).","journal-title":"J. Immunol."},{"key":"34211_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jaci.2017.12.1007","volume":"145","author":"H Suto","year":"2018","unstructured":"Suto, H. et al. IL-25 enhances TH17 cell-mediated contact dermatitis by promoting IL-1\u03b2 production by dermal dendritic cell. J. Allergy Clin. Immunol. 145, 1500\u20131509. https:\/\/doi.org\/10.1016\/j.jaci.2017.12.1007 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34211_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1365-2133.2009.09400.x","volume":"161","author":"Y Zhao","year":"2009","unstructured":"Zhao, Y. et al. Th17\/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br. J. Dermatol. 161, 1301\u20131306. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09400.x (2009).","journal-title":"Br. J. Dermatol."},{"key":"34211_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/DER.0000000000000435","volume":"30","author":"CT Sung","year":"2019","unstructured":"Sung, C. T., McGowan, M. A., Machler, B. C. & Jacob, S. E. Systemic treatments for allergic contact dermatitis. Dermatitis 30, 46\u201353. https:\/\/doi.org\/10.1097\/DER.0000000000000435 (2019).","journal-title":"Dermatitis"},{"key":"34211_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jaad.2005.02.045","volume":"52","author":"DV Belsito","year":"2005","unstructured":"Belsito, D. V. Occupational contact dermatitis: Etiology, prevalence, and resultant impairment\/disability. J. Am. Acad. Dermatol. 52, 303\u2013313. https:\/\/doi.org\/10.1016\/j.jaad.2005.02.045 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"34211_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/CBB:45:3:303","volume":"45","author":"SE Mercer","year":"2006","unstructured":"Mercer, S. E. & Friedman, E. Mirk\/Dyrk1B: A multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival. Cell Biochem. Biophys. 45, 303\u2013315. https:\/\/doi.org\/10.1385\/CBB:45:3:303 (2006).","journal-title":"Cell Biochem. Biophys."},{"key":"34211_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.12.004","author":"K Yoshida","year":"2022","unstructured":"Yoshida, K. & Yoshida, S. New insights into the roles for DYRK family in mammalian development and congenital diseases. Gene Dis. https:\/\/doi.org\/10.1016\/j.gendis.2021.12.004 (2022).","journal-title":"Gene Dis."},{"key":"34211_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.4252\/wjsc.v12.i12.1553","volume":"12","author":"N Kokkorakis","year":"2020","unstructured":"Kokkorakis, N. & Gaitanou, M. Minibrain-related kinase\/dual-specificity tyrosine-regulated kinase 1B implication in stem\/cancer stem cells biology. World J. Stem Cells 12, 1553\u20131575. https:\/\/doi.org\/10.4252\/wjsc.v12.i12.1553 (2020).","journal-title":"World J. Stem Cells"},{"key":"34211_CR11","first-page":"3631","volume":"60","author":"K Lee","year":"2000","unstructured":"Lee, K., Deng, X. & Friedman, E. Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res. 60, 3631\u20133637 (2000).","journal-title":"Cancer Res."},{"key":"34211_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.4161\/cbt.8.17.9322","volume":"8","author":"J Gao","year":"2009","unstructured":"Gao, J. et al. Mirk\/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells. Cancer Biol. Ther. 8, 1671\u20131679. https:\/\/doi.org\/10.4161\/cbt.8.17.9322 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"34211_CR13","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1158\/0008-5472.can-05-3089","volume":"66","author":"X Deng","year":"2006","unstructured":"Deng, X. et al. The kinase Mirk\/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. Cancer Res. 66, 4149\u20134158. https:\/\/doi.org\/10.1158\/0008-5472.can-05-3089 (2006).","journal-title":"Cancer Res."},{"key":"34211_CR14","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1158\/0008-5472.CAN-05-1539","volume":"66","author":"SE Mercer","year":"2006","unstructured":"Mercer, S. E., Ewton, D. Z., Shah, S., Naqvi, A. & Friedman, E. Mirk\/Dyrk1b mediates cell survival in rhabdomyosarcomas. Cancer Res. 66, 5143\u20135150. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1539 (2006).","journal-title":"Cancer Res."},{"key":"34211_CR15","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1021\/acs.jmedchem.5b00098","volume":"58","author":"JG Kettle","year":"2015","unstructured":"Kettle, J. G. et al. Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis. J. Med. Chem. 58, 2834\u20132844. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00098 (2015).","journal-title":"J. Med. Chem."},{"key":"34211_CR16","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.chembiol.2022.08.001","volume":"29","author":"L Chu","year":"2022","unstructured":"Chu, L. et al. In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system. Cell Chem. Biol. 29, 1368\u20131380. https:\/\/doi.org\/10.1016\/j.chembiol.2022.08.001 (2022).","journal-title":"Cell Chem. Biol."},{"key":"34211_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/eji.1830260424","volume":"26","author":"H Reiser","year":"1996","unstructured":"Reiser, H. & Schneeberger, E. E. Expression and function of B7\u20131 and B7\u20132 in hapten-induced contact sensitivity. Eur. J. Immunol. 26, 880\u2013885. https:\/\/doi.org\/10.1002\/eji.1830260424 (1996).","journal-title":"Eur. J. Immunol."},{"key":"34211_CR18","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.4049\/jimmunol.166.6.3672","volume":"166","author":"C Antonopoulos","year":"2001","unstructured":"Antonopoulos, C. et al. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166, 3672\u20133677. https:\/\/doi.org\/10.4049\/jimmunol.166.6.3672 (2001).","journal-title":"J. Immunol."},{"key":"34211_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2009.04.029","volume":"124","author":"T Honda","year":"2009","unstructured":"Honda, T. et al. Prostaglandin E2\u2013EP3 signaling suppresses skin inflammation in murine contact hypersensitivity. J. Allergy Clin. Immunol. 124, 809\u2013818. https:\/\/doi.org\/10.1016\/j.jaci.2009.04.029 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34211_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2689-z","volume":"19","author":"P Thitilertdecha","year":"2019","unstructured":"Thitilertdecha, P. et al. Immunosuppressive effect of hispidulin in allergic contact dermatitis. BMC Complement Altern. Med. 19, 1\u20137. https:\/\/doi.org\/10.1186\/s12906-019-2689-z (2019).","journal-title":"BMC Complement Altern. Med."},{"key":"34211_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3278","volume":"12","author":"S Hedrick","year":"2012","unstructured":"Hedrick, S., Michelini, R., Doedens, A., Goldrath, A. & Stone, E. FOXO transcription factors throughout T cell biology. Nat. Rev. Immunol. 12, 649\u2013661. https:\/\/doi.org\/10.1038\/nri3278 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"34211_CR22","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.4049\/jimmunol.1500849","volume":"195","author":"A Lain\u00e9","year":"2015","unstructured":"Lain\u00e9, A. et al. Foxo1 is a T cell-intrinsic inhibitor of the ROR\u03b3t-Th17 program. J. Immunol. 195, 1791\u20131803. https:\/\/doi.org\/10.4049\/jimmunol.1500849 (2015).","journal-title":"J. Immunol."},{"key":"34211_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.1884","volume":"11","author":"W Ouyang","year":"2010","unstructured":"Ouyang, W. et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618\u2013627. https:\/\/doi.org\/10.1038\/ni.1884 (2010).","journal-title":"Nat. Immunol."},{"key":"34211_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11581","volume":"491","author":"W Ouyang","year":"2012","unstructured":"Ouyang, W. et al. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491, 554\u2013559. https:\/\/doi.org\/10.1038\/nature11581 (2012).","journal-title":"Nature"},{"key":"34211_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","volume":"39","author":"Y Jiramongkol","year":"2020","unstructured":"Jiramongkol, Y. & Lam, E. W. FOXO transcription factor family in cancer and metastasis. Cancer Metast. Rev. 39, 681\u2013709. https:\/\/doi.org\/10.1007\/s10555-020-09883-w (2020).","journal-title":"Cancer Metast. Rev."},{"key":"34211_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/ijo.2011.1293","volume":"40","author":"J Gao","year":"2012","unstructured":"Gao, J. et al. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk\/Dyrk1B in ovarian cancer. Int. J. Oncol. 40, 1203\u20131209. https:\/\/doi.org\/10.3892\/ijo.2011.1293 (2012).","journal-title":"Int. J. Oncol."},{"key":"34211_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2017.02.033","volume":"66","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis. Hum. Pathol. 66, 48\u201358. https:\/\/doi.org\/10.1016\/j.humpath.2017.02.033 (2017).","journal-title":"Hum. Pathol."},{"key":"34211_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2012.01.015","volume":"36","author":"RR Rao","year":"2012","unstructured":"Rao, R. R., Li, Q., Gubbels Bupp, M. R. & Shrikant, P. A. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity 36, 374\u2013387. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.015 (2012).","journal-title":"Immunity"},{"key":"34211_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ni.1689","volume":"10","author":"YM Kerdiles","year":"2009","unstructured":"Kerdiles, Y. M. et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10, 176\u2013184. https:\/\/doi.org\/10.1038\/ni.1689 (2009).","journal-title":"Nat. Immunol."},{"key":"34211_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445\u2013489. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101212 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"34211_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","volume":"16","author":"J Saravia","year":"2019","unstructured":"Saravia, J., Chapman, N. M. & Chi, H. Helper T cell differentiation. Cell. Mol. Immunol. 16, 634\u2013643. https:\/\/doi.org\/10.1038\/s41423-019-0220-6 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"34211_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"M Komatsu","year":"2014","unstructured":"Komatsu, M. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368. https:\/\/doi.org\/10.1038\/nm.3432 (2014).","journal-title":"Nat. Med."},{"key":"34211_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8813558","volume":"2020","author":"JB Yan","year":"2020","unstructured":"Yan, J. B., Luo, M. M., Chen, Z. Y. & He, B. H. The function and role of the Th17\/Treg cell balance in inflammatory bowel disease. J. Immunol. Res. 2020, 1. https:\/\/doi.org\/10.1155\/2020\/8813558 (2020).","journal-title":"J. Immunol. Res."},{"key":"34211_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","volume":"72","author":"RM Talaat","year":"2015","unstructured":"Talaat, R. M., Mohamed, S. F., Bassyouni, I. H. & Raouf, A. A. Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 72, 146\u2013153. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.027 (2015).","journal-title":"Cytokine"},{"key":"34211_CR35","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1073\/pnas.1304498110","volume":"110","author":"H Ishigame","year":"2013","unstructured":"Ishigame, H. et al. Excessive Th1 responses due to the absence of TGF-\u03b2 signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis. Proc. Natl. Acad. Sci. U.S.A. 110, 6961\u20136966. https:\/\/doi.org\/10.1073\/pnas.1304498110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34211_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI13605","volume":"109","author":"A Kukreja","year":"2002","unstructured":"Kukreja, A. et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Investig. 109, 131\u2013140. https:\/\/doi.org\/10.1172\/JCI13605 (2002).","journal-title":"J. Clin. Investig."},{"key":"34211_CR37","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"A Jager","year":"2009","unstructured":"Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. & Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169\u20137177. https:\/\/doi.org\/10.4049\/jimmunol.0901906 (2009).","journal-title":"J. Immunol."},{"key":"34211_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/mmr.2016.5299","volume":"14","author":"S Bai","year":"2016","unstructured":"Bai, S., Zhang, Z., Hou, S. & Liu, X. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice. Mol. Med. Rep. 14, 671\u2013680. https:\/\/doi.org\/10.3892\/mmr.2016.5299 (2016).","journal-title":"Mol. Med. Rep."},{"key":"34211_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200801-086OC","volume":"178","author":"H Wakashin","year":"2008","unstructured":"Wakashin, H. et al. IL-23 and TH17 cells enhance TH2 cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178, 1023\u20131032. https:\/\/doi.org\/10.1164\/rccm.200801-086OC (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34211_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","volume":"193","author":"YQ Xing","year":"2018","unstructured":"Xing, Y. Q. et al. The regulation of FOXO1 and its role in disease progression. Life Sci. 193, 124\u2013131. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.030 (2018).","journal-title":"Life Sci."},{"key":"34211_CR41","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/onc.2008.25","volume":"27","author":"DN Gross","year":"2008","unstructured":"Gross, D. N., van den Heuvel, A. P. & Birnbaum, M. J. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320\u20132336. https:\/\/doi.org\/10.1038\/onc.2008.25 (2008).","journal-title":"Oncogene"},{"key":"34211_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1535-6108(02)00086-7","volume":"2","author":"S Ramaswamy","year":"2002","unstructured":"Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L. & Sellers, W. R. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2, 81\u201391. https:\/\/doi.org\/10.1016\/s1535-6108(02)00086-7 (2002).","journal-title":"Cancer Cell"},{"key":"34211_CR43","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1053\/j.gastro.2007.01.033","volume":"132","author":"M Adachi","year":"2007","unstructured":"Adachi, M. et al. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology 132, 1434\u20131446. https:\/\/doi.org\/10.1053\/j.gastro.2007.01.033 (2007).","journal-title":"Gastroenterology"},{"key":"34211_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2010.12.002","volume":"33","author":"YM Kerdiles","year":"2010","unstructured":"Kerdiles, Y. M. et al. Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890\u2013904. https:\/\/doi.org\/10.1016\/j.immuni.2010.12.002 (2010).","journal-title":"Immunity"},{"key":"34211_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.immuni.2015.01.017","volume":"42","author":"LS Stone","year":"2015","unstructured":"Stone, L. S. et al. ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfn cell differentiation. Immunity 42, 239\u2013251. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.017 (2015).","journal-title":"Immunity"},{"key":"34211_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4049\/jimmunol.196.Supp.133.38","volume":"196","author":"JM Sullivan","year":"2016","unstructured":"Sullivan, J. M. et al. T cell specific dysregulation of Foxo1 results in spontaneous inflammatory disease. J. Immunol. 196, 133. https:\/\/doi.org\/10.4049\/jimmunol.196.Supp.133.38 (2016).","journal-title":"J. Immunol."},{"key":"34211_CR47","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1073\/pnas.1820282116","volume":"116","author":"T Miyauchi","year":"2019","unstructured":"Miyauchi, T. et al. Up-regulation of FOXO1 and reduced inflammation by \u03b2-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc. Natl. Acad. Sci. U.S.A. 116, 13533\u201313542. https:\/\/doi.org\/10.1073\/pnas.1820282116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34211_CR48","doi-asserted-by":"publisher","first-page":"e147566","DOI":"10.1172\/JCI147566","volume":"132","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. The FoxO4\/DKK3 axis represses IFN-\u03b3 expression by Th1 cells and limits antimicrobial immunity. J. Clin. Investig. 132, e147566. https:\/\/doi.org\/10.1172\/JCI147566 (2022).","journal-title":"J. Clin. Investig."},{"key":"34211_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513\u2013517. https:\/\/doi.org\/10.1038\/nature11984 (2013).","journal-title":"Nature"},{"key":"34211_CR50","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.immuni.2016.05.015","volume":"44","author":"K Ichiyama","year":"2016","unstructured":"Ichiyama, K. et al. The MicroRNA-183-96-182 cluster promote Th17 cell pathogenicity by negative regulating transcription factor Foxo1 expression. Immunity 44, 1284\u20131298. https:\/\/doi.org\/10.1016\/j.immuni.2016.05.015 (2016).","journal-title":"Immunity"},{"key":"34211_CR51","doi-asserted-by":"publisher","first-page":"41347","DOI":"10.1074\/jbc.M306780200","volume":"278","author":"X Deng","year":"2003","unstructured":"Deng, X., Ewton, D. Z., Pawlikowski, B., Maimone, M. & Friedman, E. Mirk\/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation. J. Biol. Chem. 278, 41347\u201341354. https:\/\/doi.org\/10.1074\/jbc.M306780200 (2003).","journal-title":"J. Biol. Chem."},{"key":"34211_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00018-015-2032-x","volume":"73","author":"AL Ashford","year":"2016","unstructured":"Ashford, A. L. et al. Identification of DYRK1B as a substrate of ERK1\/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome. Cell. Mol. Life Sci. 73, 883\u2013900. https:\/\/doi.org\/10.1007\/s00018-015-2032-x (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"34211_CR53","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.1103015","volume":"189","author":"CF Chang","year":"2012","unstructured":"Chang, C. F. et al. Polar opposites: Erk direction of CD4 T cell subsets. J. Immunol. 189, 721\u2013731. https:\/\/doi.org\/10.4049\/jimmunol.1103015 (2012).","journal-title":"J. Immunol."},{"key":"34211_CR54","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/eji.201242889","volume":"43","author":"H Liu","year":"2013","unstructured":"Liu, H. et al. ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis. Eur. J. Immunol. 43, 1716\u20131726. https:\/\/doi.org\/10.1002\/eji.201242889 (2013).","journal-title":"Eur. J. Immunol."},{"key":"34211_CR55","doi-asserted-by":"publisher","first-page":"10885","DOI":"10.1073\/pnas.1121524109","volume":"109","author":"T Masuda","year":"2012","unstructured":"Masuda, T. et al. Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b\/Mirk and promotes proliferation of immature male germ cells in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 10885\u201310890. https:\/\/doi.org\/10.1073\/pnas.1121524109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34211_CR56","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.1038\/s41598-017-06874-w","volume":"7","author":"S Abu Jhaisha","year":"2017","unstructured":"Abu Jhaisha, S. et al. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain. Sci. Rep. 7, 6420. https:\/\/doi.org\/10.1038\/s41598-017-06874-w (2017).","journal-title":"Sci. Rep."},{"key":"34211_CR57","doi-asserted-by":"publisher","first-page":"e153724","DOI":"10.1172\/JCI153724","volume":"132","author":"N Bhat","year":"2022","unstructured":"Bhat, N. et al. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice. J. Clin. Investig. 132, e153724. https:\/\/doi.org\/10.1172\/JCI153724 (2022).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34211-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T13:04:48Z","timestamp":1682773488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34211-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34211"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34211-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2153766\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7058"}}